MAZZONI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 719
NA - Nord America 516
AS - Asia 67
SA - Sud America 1
Totale 1.303
Nazione #
PL - Polonia 532
US - Stati Uniti d'America 516
IT - Italia 79
IE - Irlanda 35
SE - Svezia 20
CN - Cina 19
HK - Hong Kong 17
GB - Regno Unito 10
JO - Giordania 10
SG - Singapore 10
VN - Vietnam 10
FR - Francia 9
BE - Belgio 7
ES - Italia 6
FI - Finlandia 6
CH - Svizzera 3
NL - Olanda 3
NO - Norvegia 3
PT - Portogallo 2
AT - Austria 1
BR - Brasile 1
DE - Germania 1
IN - India 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 1.303
Città #
Warsaw 532
Fairfield 93
Woodbridge 50
Cambridge 46
Ann Arbor 41
Florence 38
Seattle 37
Wilmington 37
Dublin 35
Chandler 29
Houston 26
Ashburn 23
Beijing 15
Hong Kong 12
Princeton 11
San Diego 11
Dong Ket 10
Altamura 9
Kent 9
Buffalo 8
Lawrence 8
Brussels 7
Barcelona 6
Medford 5
Singapore 5
Boardman 4
Boston 4
Cagliari 4
Phoenix 4
Bern 3
Dearborn 3
Falls Church 3
Oslo 3
Shanghai 3
Andover 2
Castelliri 2
Jacksonville 2
Milan 2
Monza 2
Norwalk 2
Prato 2
Siena 2
Amsterdam 1
Bremen 1
Brentford 1
Cedar Knolls 1
Foggia 1
Iesi 1
London 1
Naaldwijk 1
Redwood City 1
Rome 1
Rotterdam 1
Salerno 1
Serra 1
Sesto Fiorentino 1
São Paulo 1
Tappahannock 1
Vercurago 1
Verona 1
Vienna 1
Totale 1.169
Nome #
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 301
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 233
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 208
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 181
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 105
IN VIVO AND IN VITRO ASSESSMENT OF PREVENTIVE EFFECTS OF RANOLAZINE ON PATHOLOGICAL PHENOTYPE IN TRANSGENIC MOUSE MODELS OF HYPERTROPHIC CARDIOMYOPATHY 102
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 99
R4496C RyR2 mutation impairs atrial and ventricular contractility 94
Totale 1.323
Categoria #
all - tutte 2.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020352 32 40 13 21 44 32 33 41 29 22 41 4
2020/2021272 30 26 4 34 15 24 21 17 17 61 12 11
2021/202287 4 3 14 4 3 1 9 2 2 9 18 18
2022/2023176 20 21 11 8 15 27 23 11 27 2 5 6
2023/202458 2 11 6 0 3 4 4 17 0 0 9 2
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.323